{"id":11833,"date":"2024-11-08T14:53:38","date_gmt":"2024-11-08T06:53:38","guid":{"rendered":"https:\/\/flcube.com\/?p=11833"},"modified":"2024-11-08T14:53:40","modified_gmt":"2024-11-08T06:53:40","slug":"teva-pharmaceutical-expands-partnerships-in-chinas-one-health-sector-with-new-agreements","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=11833","title":{"rendered":"Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements"},"content":{"rendered":"\n

Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA<\/a>) has announced new partnerships with Chinese firms Zhejiang International Group Co., Ltd. and Jianmin International Co., Ltd. These collaborations aim to enhance Teva’s commercial layout in the “One Health” sector, increasing the availability of quality products for Chinese consumers.<\/p>\n\n\n\n

Strategic Agreements at the China International Import Expo<\/strong>
During the 7th China International Import Expo, Teva signed strategic cooperation agreements with Zhejiang International Group and Jianmin International, further expanding its commercialization efforts in the health sector and accelerating the introduction of high-quality products for Chinese consumers.<\/p>\n\n\n\n

Popular Health Products and Sudocrem\u00ae Success<\/strong>
Teva’s health products have been well-received in China, with the classic Irish Sudocrem\u00ae being the first health consumer product introduced by Teva in China. Suitable for various skin issues, Sudocrem\u00ae was launched in China last year through the Cross-Border E-Commerce (CBEC) channel, with successful flagship stores on Tmall International and JD.com. This year, Sudocrem\u00ae has been registered with the National Medical Products Administration (NMPA) in China, becoming a cosmetic product with a “little golden shield” for safe use on children.<\/p>\n\n\n\n

Deepening Cooperation with Zhejiang International Group<\/strong>
At the expo, Teva and Zhejiang International Group signed an agreement to further expand channels and increase the accessibility of Sudocrem\u00ae (Chinese name: Shu Duo Ke Lei), providing more Chinese consumers with high-quality skin health care options.<\/p>\n\n\n\n

Addressing Hair Loss Concerns with Minoxidil<\/strong>
Hair loss is a significant concern among young Chinese people, with epidemiological data showing that one in every five Chinese men suffers from androgenetic alopecia. According to the “2023 China Hair Health Lifestyle Blue Book,” the group of people troubled by hair issues in China is becoming more widespread and younger, with approximately 56% of women and 48% of men facing continuous hair loss.<\/p>\n\n\n\n

In the 1970s, minoxidil was found to promote hair regrowth in men and has been safely used for over 40 years, making it the highest recommended treatment in guidelines. Teva successfully registered and launched its hair growth product, Missha High, in Hong Kong a decade ago, and it remains a popular brand there.<\/p>\n\n\n\n

Strategic Partnership with Jianmin International<\/strong>
At this year’s expo, Teva brought Missha High, containing the active ingredient minoxidil, to its “first exhibition” in mainland China, offering more options for the treatment of hair loss in China. Teva and Jianmin International have reached a strategic cooperation agreement to integrate resources and collaborate in the CBEC channel, aiming to bring more high-quality products to consumers.<\/p>\n\n\n\n

Teva’s Global Health Portfolio and Commitment to China<\/strong>
As a century-old multinational pharmaceutical company, Teva has a rich and diverse product portfolio in the global health sector, helping to heal, alleviate, and prevent various diseases. Many of these products have become long-trusted classics among consumers worldwide, ranging from baby products to cold and cough treatments, vitamins, and digestive aids, catering to all age groups and providing comprehensive health care.<\/p>\n\n\n\n

Commitment to China’s Health Goals<\/strong>
Huang Diren, General Manager of Teva Greater China, said, “With the continuous improvement of living standards and health awareness, the Chinese people’s pursuit of health has become more refined and diverse. We are very pleased to have reached strategic cooperation agreements with Zhejiang International Group and Jianmin International to bring high-quality products to Chinese consumers. Committed to ‘in China, for China,’ Teva will delve into the health needs of the Chinese people, continue to explore innovative cooperation models, and work with all parties to accelerate the introduction of more high-quality product portfolios, enhancing the health and well-being of the Chinese people and contributing to the ‘Healthy China’ initiative.”-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms…<\/p>\n","protected":false},"author":1,"featured_media":11834,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1072,1071],"class_list":["post-11833","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-nyse-teva","tag-teva-pharmaceutical"],"yoast_head":"\nTeva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms Zhejiang International Group Co., Ltd. and Jianmin International Co., Ltd. These collaborations aim to enhance Teva's commercial layout in the "One Health" sector, increasing the availability of quality products for Chinese consumers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=11833\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=11833\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-08T06:53:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-08T06:53:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"441\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements\",\"datePublished\":\"2024-11-08T06:53:38+00:00\",\"dateModified\":\"2024-11-08T06:53:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833\"},\"wordCount\":610,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/1.jpg\",\"keywords\":[\"NYSE: TEVA\",\"Teva Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=11833#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=11833\",\"name\":\"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/1.jpg\",\"datePublished\":\"2024-11-08T06:53:38+00:00\",\"dateModified\":\"2024-11-08T06:53:40+00:00\",\"description\":\"Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms Zhejiang International Group Co., Ltd. and Jianmin International Co., Ltd. These collaborations aim to enhance Teva's commercial layout in the \\\"One Health\\\" sector, increasing the availability of quality products for Chinese consumers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=11833\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/1.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/1.jpg\",\"width\":599,\"height\":441,\"caption\":\"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11833#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements - Insight, China's Pharmaceutical Industry","description":"Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms Zhejiang International Group Co., Ltd. and Jianmin International Co., Ltd. These collaborations aim to enhance Teva's commercial layout in the \"One Health\" sector, increasing the availability of quality products for Chinese consumers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=11833","og_locale":"en_US","og_type":"article","og_title":"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=11833","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-11-08T06:53:38+00:00","article_modified_time":"2024-11-08T06:53:40+00:00","og_image":[{"width":599,"height":441,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=11833#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=11833"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements","datePublished":"2024-11-08T06:53:38+00:00","dateModified":"2024-11-08T06:53:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=11833"},"wordCount":610,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=11833#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","keywords":["NYSE: TEVA","Teva Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=11833#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=11833","url":"https:\/\/flcube.com\/?p=11833","name":"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=11833#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=11833#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","datePublished":"2024-11-08T06:53:38+00:00","dateModified":"2024-11-08T06:53:40+00:00","description":"Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms Zhejiang International Group Co., Ltd. and Jianmin International Co., Ltd. These collaborations aim to enhance Teva's commercial layout in the \"One Health\" sector, increasing the availability of quality products for Chinese consumers.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=11833#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=11833"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=11833#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","width":599,"height":441,"caption":"Teva Pharmaceutical Expands Partnerships in China's One Health Sector with New Agreements"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=11833#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Teva Pharmaceutical Expands Partnerships in China’s One Health Sector with New Agreements"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/1.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11833"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11833\/revisions"}],"predecessor-version":[{"id":11835,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11833\/revisions\/11835"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/11834"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}